Showing results (151-160 of 197) with videos related to
Sort By:
Pageof 20
Molecular Pharmacology|April 14, 2012
Crotamine pharmacology revisited: novel insights based on the inhibition of KV channelsSteve Peigneur, Diego J B Orts, Alvaro R Prieto da Silva, et al.Peptides|June 15, 2013
A novel sea anemone peptide that inhibits acid-sensing ion channelsArmando Alexei Rodríguez, Emilio Salceda, Anoland Georgina Garateix, et al.International Journal of Molecular Sciences|May 14, 2022
Kunitz-Type Peptides from Sea Anemones Protect Neuronal Cells against Parkinson's Disease Inductors via Inhibition of ROS Production and ATP-Induced P2X7 Receptor ActivationAleksandra Kvetkina, Evgeny Pislyagin, Ekaterina Menchinskaya, et al.Biochemical Pharmacology|February 19, 2022
Bradykinin induces peripheral antinociception in PGE<sub>2</sub>-induced hyperalgesia in miceRenata Cristina Mendes Ferreira, Flávia Cristina de Sousa Fonseca, Douglas Lamounier de Almeida, et al.Biochemical Pharmacology|June 12, 2020
Pharmacological activity and NMR solution structure of the leech peptide HSTX-IKirsten L McMahon, Bryan Tay, Jennifer R Deuis, et al.The FEBS Journal|July 31, 2013
BcsTx3 is a founder of a novel sea anemone toxin family of potassium channel blockerDiego J B Orts, Yehu Moran, Camila T Cologna, et al.Marine Drugs|March 8, 2013
Biochemical and electrophysiological characterization of two sea anemone type 1 potassium toxins from a geographically distant population of Bunodosoma caissarumDiego J B Orts, Steve Peigneur, Bruno Madio, et al.Structure (London, England : 1993)|December 18, 2018
A Centipede Toxin Family Defines an Ancient Class of CSαβ DefensinsThomas S Dash, Thomas Shafee, Peta J Harvey, et al.Toxins|January 16, 2020
New Insights into the Type II Toxins from the Sea Anemone <i>Heteractis crispa</i>Rimma S Kalina, Steve Peigneur, Elena A Zelepuga, et al.Peptides|September 24, 2013
A 'conovenomic' analysis of the milked venom from the mollusk-hunting cone snail Conus textile--the pharmacological importance of post-translational modificationsZachary L Bergeron, Joycelyn B Chun, Margaret R Baker, et al.Pageof 20